| Literature DB >> 35408422 |
Yasmine Heyer1, Daniela Baumgartner2, Christian Baumgartner1.
Abstract
For cardiac defibrillator testing and design purposes, the range and limits of the human TTI is of high interest. Potential influencing factors regarding the electronic configurations, the electrode/tissue interface and patient characteristics were identified and analyzed. A literature survey based on 71 selected articles was used to review and assess human TTI and the influencing factors found. The human TTI extended from 12 to 212 Ω in the literature selected. Excluding outliers and pediatric measurements, the mean TTI recordings ranged from 51 to 112 Ω with an average TTI of 76.7 Ω under normal distribution. The wide range of human impedance can be attributed to 12 different influencing factors, including shock waveforms and protocols, coupling devices, electrode size and pressure, electrode position, patient age, gender, body dimensions, respiration and lung volume, blood hemoglobin saturation and different pathologies. The coupling device, electrode size and electrode pressure have the greatest influence on TTI.Entities:
Keywords: defibrillation; impedance distribution; influencing factors; transthoracic impedance
Mesh:
Year: 2022 PMID: 35408422 PMCID: PMC9003563 DOI: 10.3390/s22072808
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Figure 1Keyword combinations which were used for the literature search.
Inclusion and exclusion criteria for the analysis of TTI influencing factors and meta-analysis of human TTI measurements.
| Exclusion Criteria | Inclusion Criteria | |
|---|---|---|
| Reported Outcomes | No mention of TTI | Human and animal TTI measurements and analysis of factors influencing TTI |
| Exposure of Interest | TTI without connection to defibrillation | Defibrillation and cardioversion |
| Implanted device-based methods | Electrode and paddle TTI measurements | |
| Relationship between tidal volume and TTI amplitude | ||
| Transthoracic impedance cardiography | ||
| Setting | Impedance tracking in real time | Outpatient and inpatient hospital reports |
| Date | Papers published before 1970 | Papers published 1970–2021 |
| Language | Non-English | English |
| Additional criteria for meta-analysis of human TTI measurements | Animal measurements | Human TTI measurements only |
| Crucial data missing (mean, highest and lowest) | Documentation of at least mean, highest or lowest TTI | |
| Case studies | Minimum of 5 subjects |
Figure 2PRISMA 2020 flow diagram for updated systematic reviews which included searches of databases and other sources. See Page et al., 2021 [6]. For more information, visit: http://www.prisma-statement.org/ (accessed on 15 February 2022 ) [6].
TTI measurements from the literature research. Measurements performed in a study and their results are associated with the different measurement configurations.
| No. | Sources | TTI in Ω | Year | Patients | Age in Years | Weight in kg | Electrodes | Current | Waveform | TTI Measurement Details | Arrythmia | Additional Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | Lowest | Highest |
| Female | Male | Mean | SD | Mean | SD | Area in cm2 | Type | Position | in kHz | |||||||
| 1 | [ | 60.00 | 31.00 | 15.00 | 143.00 | 1981 | 44 | - | - | - | - | 72 | - | 57 | paddles | AL | - | damped sinosoid | calculation | vf | - |
| 2 | 67.00 | 36.00 | 16.00 | 143.00 | 1981 | 21 | - | - | - | - | - | - | 133 | paddles | AL | - | damped sinosoid | calculation | vf | - | |
| 3 | 53.00 | 24.00 | 12.00 | 132.00 | 1981 | 23 | - | - | - | - | - | - | 57 | paddles | AL | - | damped sinosoid | calculation | vf | - | |
| 4 | [ | 90.00 | 23.00 | 27.00 | 152.00 | 2005 | 102 | - | - | - | - | - | - | - | - | - | - | biphasic | calculation | vf, vt | - |
| 5 | [ | 75.00 | 21.00 | 28.00 | 150.00 | 1988 | 347 | - | - | - | - | - | - | - | paddles/pads | - | - | damped sinosoid | monitored by a microprocessor | vf, vt, af | - |
| 6 | [ | 65.00 | 14.00 | 46.00 | 85.00 | 1990 | 10 | 2 | 8 | 55 | 20 | - | - | 60 | pads | AL | - | - | calculation | - | - |
| 7 | [ | 107.20 | 22.30 | 58.00 | 152.00 | 2006 | 86 | 49 | 39 | 57 | 14 | 76 | 15 | 92 | pads | AL | 32.00 | - | high-frequency impedance | none | - |
| 8 | 96.60 | 19.20 | 55.00 | 149.00 | 2006 | 86 | 49 | 39 | 57 | 14 | 76 | 15 | 92 | pads | AP | 32.00 | - | high-frequency impedance | none | - | |
| 9 | [ | 93.00 | 3.00 | 38.00 | 137.00 | 1991 | 70 | 20 | 50 | 66 | 5 | - | - | 50/113 | pads | AA | 30.00 | - | high-frequency impedance | vf | - |
| 10 | [ | 112.00 | 17.00 | - | - | 1989 | 105 | 31 | 74 | 64 | - | - | - | 50 | pads | AA | 30.00 | - | high-frequency impedance | vf | - |
| 11 | 92.30 | 22.00 | - | - | 1989 | 63 | - | - | 64 | - | - | - | 50/113 | pads | AA | 30.00 | - | high-frequency impedance | vf | - | |
| 12 | 71.60 | 14.00 | - | - | 1989 | 34 | - | - | 64 | - | - | - | 113 | pads | AA | 30.00 | - | high-frequency impedance | vf | - | |
| 13 | [ | 77.50 | 18.40 | - | - | 1999 | 45 | - | - | 66 | 10 | - | - | 106 | pads | AA | 18.00 | - | calculation | af | - |
| 14 | 73.70 | 18.40 | - | - | 1999 | 45 | - | - | 66 | 10 | - | - | 106 | pads | AP | 18.00 | - | calculation | af | - | |
| 15 | 75.60 | 18.50 | 43.00 | 133.00 | 1999 | 90 | 30 | 60 | 66 | 10 | - | - | 106 | pads | AA or AP | 18.00 | - | calculation | af | during first shock | |
| 16 | 68.80 | 15.40 | - | - | 1999 | 90 | 30 | 60 | 66 | 10 | - | - | 106 | pads | AA or AP | 18.00 | - | calculation | af | during last shock | |
| 17 | [ | 95.00 | 25.00 | - | - | 1996 | 25 | 25 | - | - | - | 85 | 22 | - | paddles | AA | 31.25 | square wave | high-frequency impedance | - | on breast |
| 18 | 84.00 | 17.00 | - | - | 1996 | 25 | 25 | - | - | - | 85 | 22 | - | paddles | AA | 31.25 | square wave | high-frequency impedance | - | under breast | |
| 19 | 83.00 | 20.00 | - | - | 1996 | 25 | 25 | - | - | - | 85 | 22 | - | paddles | AA | 31.25 | square wave | high-frequency impedance | - | lateral to breast | |
| 20 | [ | 78.10 | 19.40 | 28.00 | 118.00 | 1984 | 19 | - | - | - | - | - | - | - | paddles | - | 31.00 | - | high-frequency impedance | vf, vt, af | - |
| 21 | [ | 74.00 | 29.00 | - | - | 1996 | 100 | - | - | - | - | - | - | 57/113 | paddles/pads | AA or AP | - | damped sinosoid | first shock impedance | vf, vt | - |
| 22 | [ | 69.90 | 14.00 | 41.00 | 100.00 | 1989 | 40 | 7 | 33 | 62 | - | - | - | 113 | pads | AA | 30.00 | - | high-frequency impedance | vf, aa | pre-gelled |
| 23 | 65.10 | 15.90 | 38.00 | 97.00 | 1989 | 41 | 12 | 29 | 63 | - | - | - | 113 | pads | AA | 30.00 | - | high-frequency impedance | vf | pre-gelled | |
| 24 | [ | - | - | 55.00 | 125.00 | 2001 | 15 | - | - | 59 | 9 | 81 | 13 | 65 | paddles | - | 50.00 | biphasic | high-frequency impedance | af | - |
| 25 | [ | 75.00 | 21.00 | 28.00 | 150.00 | 1984 | 68 | - | - | - | - | - | - | 50/113 | pads | AA or AP | - | - | - | vt,vf, af | - |
| 26 | 79.00 | 26.00 | - | - | 1984 | 68 | - | - | - | - | - | - | 50/113 | pads | AA | - | - | - | vt,vf, af | - | |
| 27 | 73.00 | 16.00 | - | - | 1984 | 68 | - | - | - | - | - | - | 50/113 | pads | AP | - | - | - | vt,vf, af | - | |
| 28 | [ | 77.00 | 18.00 | - | - | 1992 | 17 | - | - | - | - | - | - | - | paddles | AA | 31.25 | square wave | high-frequency impedance | none | without sternotomy |
| 29 | 59.00 | 17.00 | - | - | 1992 | 17 | - | - | - | - | - | - | - | paddles | AA | 31.25 | square wave | high-frequency impedance | none | with sternotomy | |
| 30 | [ | 82.00 | 24.70 | - | - | 1998 | 20 | 10 | 10 | 42 | 18 | - | - | 78 | pads | AA | 31.25 | square wave | high-frequency impedance | none | - |
| 31 | 71.20 | 23.50 | - | - | 1998 | 20 | 10 | 10 | 42 | 18 | - | - | 78 | pads | AP | 31.25 | square wave | high-frequency impedance | none | - | |
| 32 | 77.00 | 24.70 | - | - | 1998 | 20 | 10 | 10 | 42 | 18 | - | - | 78 | pads | AP | 31.25 | square wave | high-frequency impedance | none | - | |
| 33 | [ | 81.48 | 13.34 | - | - | 2003 | 20 | 7 | 13 | - | - | - | - | 90 | paddles | AA (trans.) | - | - | modified defibrillator | - | at end-expiration with 6 kg force |
| 34 | 77.58 | 13.25 | - | - | 2003 | 20 | 7 | 13 | - | - | - | - | 90 | paddles | AA (long.) | - | - | modified defibrillator | - | at end-expiration with 6 kg force | |
| 35 | [ | 70.50 | 1.00 | - | - | 2004 | 35 | 7 | 28 | - | - | - | - | 85 | paddles | AA | - | - | using Labview (National Instruments) | - | on gel pads, with variable lung volume |
| 36 | 72.25 | 1.00 | - | - | 2004 | 35 | 7 | 28 | - | - | - | - | 85 | paddles | AA | - | - | using Labview (National Instruments) | - | on gel pads, with fixed lung volume | |
| 37 | [ | 92.20 | - | 52.00 | 126.00 | 2008 | 58 | 12 | 46 | 68 | - | 85 | - | - | pads | AA | - | biphasic | first shock impedance | af | - |
| 38 | [ | 86.00 | - | 73.00 | 103.00 | 2009 | 467 | - | - | - | - | - | - | - | pads | - | - | biphasic | shock impedance | vf | - |
| 39 | [ | 65.70 | 6.90 | - | - | 1998 | 12 | 6 | 6 | 30 | - | - | - | - | pads | AA | 30.00 | damped sinosoid | Bodystat MultiScan 5000 | none | at end-expiration |
| 40 | [ | 68.20 | 16.10 | - | - | 1998 | 40 | 0 | 40 | 32 | - | - | - | 82 | paddles | AA | 30.00 | damped sinosoid | Bodystat MultiScan 5000 | none | at end-expiration |
| 41 | 62.80 | 13.20 | - | - | 1998 | 40 | 0 | 40 | 33 | - | - | - | 99 | paddles | AA | 30.00 | damped sinosoid | Bodystat MultiScan 5000 | none | at end-expiration | |
| 42 | 64.60 | 14.30 | - | - | 1998 | 40 | 0 | 40 | 34 | - | - | - | 85 | paddles | AA | 30.00 | damped sinosoid | Bodystat MultiScan 5000 | none | at end-expiration | |
| 43 | 95.60 | 22.30 | - | - | 1998 | 40 | 0 | 40 | 35 | - | - | - | 64 | paddles | AA | 30.00 | damped sinosoid | Bodystat MultiScan 5000 | none | at end-expiration | |
| 44 | [ | 91.30 | 15.80 | 63.00 | 137.70 | 2001 | 45 | 45 | 0 | 32 | - | 82 | - | - | pads | AA | 30.00 | monophasic | Bodystat MultiScan 5000 | none | 2 weeks before estimated date of delivery |
| 45 | 91.60 | 11.50 | 69.30 | 118.30 | 2001 | 42 | 42 | 0 | 32 | - | 71 | - | - | pads | AA | 30.00 | monophasic | Bodystat MultiScan 5000 | none | 6–8 weeks after delivery | |
| 46 | [ | 57.70 | 11.40 | - | - | 2009 | 222 | 73 | 149 | 73 | 11 | 75 | 13 | 78 | pads | AP | 5.00 | biphasic | calculation | af | first shock |
| 47 | 54.10 | 10.80 | - | - | 2009 | 222 | 73 | 149 | 73 | 11 | 75 | 13 | 78 | pads | AP | 5.00 | biphasic | calculation | af | last shock | |
| 48 | [ | 91.00 | 13.00 | - | - | 2002 | 107 | 34 | 73 | 65 | 13 | 88 | 24 | 167 | card. electrodes | AP | - | monophasic | shock impedance | af | failed cardioversion in ≤4 shocks |
| 49 | 79.00 | 19.00 | - | - | 2002 | 107 | 34 | 73 | 65 | 13 | 88 | 24 | 167 | card. electrodes | AP | - | monophasic | shock impedance | af | no failed cardioversion | |
| 50 | 76.00 | 6.00 | - | - | 2002 | 96 | 27 | 69 | 65 | 14 | 87 | 19 | 167 | card. electrodes | AP | - | biphasic | shock impedance | af | failed cardioversion in ≤4 shocks | |
| 51 | 76.00 | 18.00 | - | - | 2002 | 96 | 27 | 69 | 65 | 14 | 87 | 19 | 167 | card. electrodes | AP | - | biphasic | shock impedance | af | no failed cardioversion | |
| 52 | [ | 104.00 | 27.00 | - | - | 2008 | 467 | 89 | 378 | 63 | 14 | - | - | - | paddles | - | - | biphasic | high-frequency impedance | vf | all |
| 53 | 109.00 | 27.00 | - | - | 2008 | 89 | 89 | 0 | - | - | - | - | - | paddles | - | - | biphasic | high-frequency impedance | vf | only women | |
| 54 | 103.00 | 27.00 | - | - | 2008 | 378 | 0 | 378 | - | - | - | - | - | paddles | - | - | bipasic | high-frequency impedance | vf | only men | |
| 55 | 104.00 | 26.00 | - | - | 2008 | 467 | 89 | 378 | 63 | 14 | - | - | - | paddles | - | - | biphasic | high-frequency impedance | vf | 1991 successful shocks | |
| 56 | 102.00 | 22.00 | - | - | 2008 | 467 | 89 | 378 | 63 | 14 | - | - | - | paddles | - | - | biphasic | high-frequency impedance | vf | 536 failed shocks | |
| 57 | [ | 58.00 | 10.30 | - | - | 1997 | 10 | 5 | 5 | - | - | - | - | - | paddles | AA | 31.25 | square wave | high-frequency impedance | none | - |
| 58 | 51.00 | 10.90 | - | - | 1997 | 10 | 5 | 5 | - | - | - | - | - | paddles | AA | 31.25 | square wave | high-frequency impedance | none | - | |
| 59 | 36.00 | 7.60 | - | - | 1997 | 10 | 5 | 5 | - | - | - | - | - | paddles | AA | 31.25 | square wave | high-frequency impedance | none | with gel smear | |
| 60 | 51.00 | 8.00 | - | - | 1997 | 10 | 5 | 5 | - | - | - | - | - | paddles | AA | 31.25 | square wave | high-frequency impedance | none | with gel smear | |
| 61 | [ | 57.70 | 12.30 | 37.00 | 89.00 | 2006 | 80 | 25 | 55 | 73 | 9 | 74 | 13 | 78 | pads | AP | 5.00 | biphasic | shock impedance | af | - |
| 62 | [ | 73.80 | 16.80 | - | - | 2003 | 31 | 11 | 20 | 59 | 15 | 68 | 115 | - | pads | AL | - | damped sinosoid | modified Hewlett-Packard defibrillator | af | - |
| 63 | 65.50 | 14.50 | - | - | 2003 | 39 | 12 | 27 | 58 | 10 | 67 | 16 | - | pads | AP | - | damped sinosoid | modified Hewlett-Packard defibrillator | af | - | |
| 64 | [ | 78.00 | 16.00 | 41.00 | 124.00 | 1999 | 88 | 29 | 59 | 65 | 12 | 89 | 21 | 78/113 | gel pads | AP | - | biphasic | shock impedance | af | - |
| 65 | 76.00 | 17.00 | 40.00 | 112.00 | 1999 | 77 | 21 | 56 | 66 | 12 | 93 | 24 | 78/113 | gel pads | AP | - | damped sinosoid | shock impedance | af | - | |
| 66 | [ | 90.00 | 21.00 | - | - | 2005 | 150 | 55 | 95 | 67 | 10 | - | - | - | pads | AA | - | biphasic | shock impedance | af | - |
| 67 | 85.00 | 18.00 | - | - | 2005 | 157 | 57 | 100 | 66 | 14 | - | - | - | pads | AP | - | biphasic | shock impedance | af | - | |
| 68 | [ | 69.30 | 16.00 | 39.00 | 131.00 | 1990 | 80 | 31 | 49 | 62 | - | - | - | 50/113 | pads | AP or AA | 30.00 | - | - | af | - |
| 69 | 66.70 | 16.00 | - | - | 1990 | 57 | - | - | - | - | - | - | 50/113 | pads | AP | 30.00 | - | - | af | - | |
| 70 | 75.40 | 13.00 | - | - | 1990 | 23 | - | - | - | - | - | - | 50/113 | pads | AA | 30.00 | - | - | af | - | |
| 71 | [ | 59.20 | 8.10 | - | - | 1998 | 10 | 2 | 8 | - | - | - | - | - | pads | AA | 30.00 | sinosoid | high-frequency impedance | none | Air |
| 72 | 60.40 | 7.90 | - | - | 1999 | 10 | 2 | 8 | - | - | - | - | - | pads | AA | 30.00 | sinosoid | high-frequency impedance | none | 100% O2 | |
| 73 | 60.60 | 7.80 | - | - | 2000 | 10 | 2 | 8 | - | - | - | - | - | pads | AA | 30.00 | sinosoid | high-frequency impedance | none | 30% O2 + 70% N2O | |
| 74 | 60.00 | 8.80 | - | - | 2001 | 10 | 2 | 8 | - | - | - | - | - | pads | AA | 30.00 | sinosoid | high-frequency impedance | none | 30% O | |
| 75 | [ | 75.80 | 14.10 | - | - | 2004 | 21 | 7 | 14 | 70 | - | 80 | - | 82 | paddles | AA | 30.00 | sinosoid | high-frequency impedance | af | - |
| 76 | 92.60 | 16.99 | - | - | 2004 | 21 | 7 | 14 | 70 | - | 80 | - | 80 | pads | AA | 30.00 | sinosoid | high-frequency impedance | af | - | |
| 77 | 66.50 | 13.90 | - | - | 2004 | 21 | 7 | 14 | 70 | - | 80 | - | 82 | paddles | AP | 30.00 | sinosoid | high-frequency impedance | af | - | |
| 78 | 92.10 | 23.30 | - | - | 2004 | 21 | 7 | 14 | 70 | - | 80 | - | 80 | pads | AP | 30.00 | sinosoid | high-frequency impedance | af | - | |
| 79 | [ | 162.00 | 11.00 | - | - | 2000 | 9 | 0 | 9 | - | - | - | - | 164 or 192 | pads | AA | 31.25 | square wave | high-frequency impedance | none | hirsute patients |
| 80 | 103.00 | 6.00 | - | - | 2000 | 11 | 5 | 6 | - | - | - | - | 164 or 192 | pads | AA | 31.25 | square wave | high-frequency impedance | none | non -hirsute patients | |
| 81 | 105.00 | 3.00 | - | - | 2000 | 9 | 0 | 9 | - | - | - | - | 164 or 192 | pads | AA | 31.25 | square wave | high-frequency impedance | none | shaved hirsute group | |
| 82 | [ | 78.50 | 6.40 | - | - | 2003 | 15 | - | - | - | - | - | - | 143 | paddles | AA | - | - | modified defibrillator | none | hirsute patients at 8 kgf |
| 83 | 71.50 | 5.40 | - | - | 2003 | 15 | - | - | - | - | - | - | 143 | paddles | AA | - | - | modified defibrillator | none | hirsute patients at 8 kgf, after shaving | |
| 84 | 73.20 | 4.90 | - | - | 2003 | 25 | - | - | - | - | - | - | 143 | paddles | AA | - | - | modified defibrillator | none | non -hirsute patients at 8 kgf | |
| 85 | 72.50 | 5.10 | - | - | 2003 | 25 | - | - | - | - | - | - | 143 | paddles | AA | - | - | modified defibrillator | none | non -hirsute patients at 8 kgf, after shaving | |
| 86 | 65.10 | 4.80 | - | - | 2003 | 10 | - | - | - | - | - | - | 143 | paddles | AA | - | - | modified defibrillator | none | non -hirsute patients at 8 kgf, control group | |
| 87 | [ | 54.00 | 4.00 | - | - | 1988 | 37 | - | - | - | - | - | - | - | pads | AA | 31.24 | square wave | high-frequency impedance | aa, va, none | salt-containing coupling agent |
| 88 | 65.00 | 5.00 | - | - | 1988 | 37 | - | - | - | - | - | - | - | pads | AA | 31.24 | square wave | high-frequency impedance | aa, va, none | salt-free coupling agent | |
| 89 | 160.00 | 18.00 | - | - | 1988 | 37 | - | - | - | - | - | - | - | pads | AA | 31.24 | square wave | high-frequency impedance | aa, va, none | no coupling agent | |
| 90 | [ | 108.00 | 24.00 | 61.00 | 212.00 | 1988 | 37 | - | - | - | - | - | - | 21 | paddles | - | - | - | high-frequency impedance | none | pediatric data, children 1.5–15 years |
| 91 | 57.00 | 11.00 | 29.00 | 101.00 | 1988 | 37 | - | - | - | - | - | - | 83 | paddles | - | - | - | high-frequency impedance | none | pediatric data, children 1.5–15 years | |
| 92 | 94.00 | 17.00 | 74.00 | 124.00 | 1988 | 10 | - | - | - | - | - | - | 21 | paddles | - | - | - | high-frequency impedance | none | pediatric data, infants 6 weeks to 9 months | |
| 93 | [ | 56.80 | 23.40 | 27.70 | 94.50 | 2010 | 5 | 3 | 2 | 14 | 5 | 47 | 7 | - | pads | AA | - | biphasic | - | cardiac arrest | pediatric data, 0.1 pre-shock and post-shock |
| 94 | 55.20 | 22.20 | 28.30 | 93.10 | 2010 | 5 | 3 | 2 | 14 | 5 | 47 | 7 | - | pads | AA | - | biphasic | - | cardiac arrest | pediatric data, 0.1 s post-shock baseline | |
| 95 | [ | 106.80 | - | - | - | 2003 | 12 | - | - | 1 | - | 7 | - | 16 | paddles | AA | - | - | using Labview (National Instruments) | - | pediatric data, on gel pads |
| 96 | 53.30 | - | - | - | 2003 | 68 | - | - | 3 | - | 16 | - | 85 | paddles | AA | - | - | using Labview (National Instruments) | - | pediatric data, on gel pads | |
| 97 | 69.30 | - | - | - | 2003 | 68 | - | - | 13 | - | 44 | - | 85 | paddles | AA | - | - | using Labview (National Instruments) | - | pediatric data, on gel pads | |
| 98 | [ | 148.00 | 23.00 | - | - | 1995 | 24 | - | - | 4 | 3 | 6 | 16 | 13 | pads | AA | 31.00 | square wave | high-frequency impedance | none | pediatric data |
| 99 | 49.00 | 9.00 | - | - | 1995 | 9 | - | - | 4 | 3 | - | - | 79 | pads | AA | 31.00 | square wave | high-frequency impedance | none | pediatric data | |
| 100 | [ | 73.60 | 20.70 | 26.00 | 146.00 | 2017 | 593 | - | - | - | - | - | - | - | - | - | - | biphasic | Philips HeartStart XL/ HeartStart MRx defibrillators | atrial fibrillation | first shock TTI |
| 101 | 76.60 | 22.60 | 26.00 | 146.00 | 2017 | 110 | - | - | - | - | - | - | - | - | - | - | biphasic | Philips HeartStart XL/ HeartStart MRx defibrillators | atrial flutter | first shock TTI | |
| 102 | [ | 74.00 | 18.00 | - | - | 2018 | 500 | 129 | 371 | 66 | 11 | 95 | 24 | - | - | - | - | biphasic | LIFEPAK 20e/ HeartStart XL | af | first shock TTI |
| 103 | 74.00 | 18.00 | - | - | 2018 | 500 | 129 | 371 | 66 | 11 | 95 | 24 | - | - | - | - | biphasic | LIFEPAK 20e/ HeartStart XL | af | maximum | |
| 104 | 70.00 | 16.00 | - | - | 2018 | 389 | 100 | 289 | 66 | 11 | 96 | 25 | - | paddles/pads | AP | - | biphasic | LIFEPAK 20e/ HeartStart XL | af | Using OAFCP, first shock TTI | |
| 105 | 71.00 | 16.00 | - | - | 2018 | 389 | 100 | 289 | 66 | 11 | 96 | 25 | - | paddles/pads | AP/AL | - | biphasic | LIFEPAK 20e/ HeartStart XL | af | Using OAFCP, maximum | |
| 106 | [ | 79.00 | 4.40 | 73.00 | 84.00 | 2020 | 5 | 0 | 5 | 54 | 11 | - | - | - | paddles | AL | - | biphasic | Standard direct-current ec | af | - |
| 107 | [ | 64.00 | 11.00 | - | - | 2021 | 466 | 90 | 376 | 60 | 11 | - | - | - | pads | AP | - | biphasic | HeartStart MRx, after energy delivery | af, at, aa | - |
| 108 | 63.00 | 11.00 | - | - | 2021 | 376 | 0 | 376 | - | - | - | - | - | pads | AP | - | biphasic | HeartStart MRx, after energy delivery | af, at, aa | male | |
| 109 | 77.00 | 15.00 | - | - | 2021 | 90 | 90 | 0 | - | - | - | - | - | pads | AP | - | biphasic | HeartStart MRx, after energy delivery | af, at, aa | female | |
| 110 | [ | 78.00 | 21.40 | 32.00 | 154.00 | 2017 | 92 | 19 | 73 | 64 | 17 | - | - | - | pads | - | 20.00 | biphasic | calculated (LIFEPAK 12) | vf | no return of spontaneous circulation |
| 111 | 73.80 | 20.40 | 32.00 | 154.00 | 2017 | 105 | 33 | 72 | 63 | 14 | - | - | - | pads | - | 20.00 | biphasic | calculated (LIFEPAK 12) | vf | return of spontaneous circulation | |
| 112 | [ | 81.40 | 17.6 | - | - | 2016 | 11 | 0 | 11 | - | - | - | - | - | pads | AL | - | - | calibrated impedance circuit | none | shaved hirsute, at rest |
| 113 | 85.60 | 16.50 | - | - | 2016 | 11 | 0 | 11 | - | - | - | - | - | pads | AL | - | - | calibrated impedance circuit | none | shaved hirsute, at inspiration | |
| 114 | 79.60 | 19.20 | - | - | 2016 | 11 | 0 | 11 | - | - | - | - | - | pads | AL | - | - | calibrated impedance circuit | none | shaved hirsute, at end-expiration | |
| 115 | 74.90 | 17.30 | - | - | 2016 | 11 | 0 | 11 | - | - | - | - | - | pads | AL | - | - | calibrated impedance circuit | none | shaved hirsute, applied force (6-15 kgf) | |
| 116 | 70.90 | 16.6 | - | - | 2016 | 11 | 0 | 11 | - | - | - | - | - | pads | AP | - | - | calibrated impedance circuit | none | shaved hirsute, at rest | |
| 117 | 73.90 | 16.20 | - | - | 2016 | 11 | 0 | 11 | - | - | - | - | - | pads | AP | - | - | calibrated impedance circuit | none | shaved hirsute, at inspiration | |
| 118 | 70.00 | 16.40 | - | - | 2016 | 11 | 0 | 11 | - | - | - | - | - | pads | AP | - | - | calibrated impedance circuit | none | shaved hirsute, at end-expiration | |
| 119 | 67.10 | 14.80 | - | - | 2016 | 11 | 0 | 11 | - | - | - | - | - | pads | AP | - | - | calibrated impedance circuit | none | shaved hirsute, applied force (6–15 kgf) | |
Table explanations: ‘-’ stands for missing data; Electrode areas are given as first electrode/second electrode; card. electrode = cardioversion electrode; energy is given in min-max energy; none = no defibrillation shock and/or arrhythmia; defi. = defibrillation; AA, AL, AP, vf, vt, af, va, aa see abbreviations.
Statistical analysis of mean TTI, maximum and minimum TTI of all collected data.
| Statistical Calculation | TTI in Ω | |||
|---|---|---|---|---|
| Minimum | Mean | Maximum | SD | |
| Mean TTI | 41.0 | 77.8 | 127.8 | 16.4 |
| Maximum TTI | 74.0 | 162.0 | 212.0 | 36.0 |
| Minimum TTI | 12.0 | 36.0 | 84.0 | 3.0 |
| sample size (n) | 32 | 118 | 32 | 100 |
Figure 3TTI data from Table A1 shown as histograms. In each subgraph, the number of trials used for histogram analysis is denoted by ‘n’.
Figure 4TTI data from Table A1 shown as boxplots. In each subgraph, the number of trials used for box plot analysis is denoted by ‘n’ below the graphs. The red line in the box indicates the median value. The upper and lower box boundaries represent the 25th and 75th percentiles, respectively. The most extreme data points are represented by the whiskers, excluding outliers. The latter are marked by a ‘+’ symbol.
Figure 5All TTI influencing factors found in the literature review and categorization into the different impedance determining components.
Figure 6Positioning of the electrodes: AP positions (blue), AA positions (green) and AL positions (orange) each consist of two electrodes. The exact placement is indicated by the numbers and colors. For further reference, the additional abbreviations (AP1, AP2, etc.) are used in the text.
Different AA vs. AP TTI measurements: A comparison of the literature. The symbol AP without specification was denoted when no further information on AP position was available.
| Literature | AA/AL Placement | AP Placement | TTI in AA Position | Mean TTI in AP Position | ||
|---|---|---|---|---|---|---|
| [ | AA1 | AP |
|
| 31 | 39 |
| [ | AA1 | AP |
|
| 23 | 57 |
| [ | AA1 | AP1 |
|
| 20 | 20 |
| [ | AA3 | AP5 |
|
| 17 | 17 |
| [ | AA | AP |
|
| 45 | 45 |
| [ | AA1 | AP4 |
|
| 150 | 157 |
| [ | AL | AP2 |
|
| 86 | 86 |
| [ | AA1 | AP6 |
|
| 21 | 21 |
| [ | AA1 | AP6 |
|
| 21 | 21 |
| [ | AL | AP |
|
| 11 | 11 |
TTI mean ± SD () in relation to age (in years) and BSA (in m) with [42].
| TTI | Age ≤ 42 | Age > 42 |
|---|---|---|
| BSA < 1.8 |
|
|
| BSA > 1.8 |
|
|
Mean ± SD () of TTI at rest under different conditions determined by electrode position and gel application techniques in men () and women () [14].
| Electrode Position | Gel Application Technique | Male Mean TTI ± SD ( | Female Mean TTI ± SD ( |
|---|---|---|---|
| Apex-to-anterior | Paddles only |
|
|
| Parasternal-to-anterior | Paddles only |
|
|
| Parasternal-to-anterior | Smeared |
|
|
| Apex-to-anterior | Smeared |
|
|
Factors influencing TTI found from the literature research are categorized according to the degree of influence (low, medium and high). An increase (↑) or decrease (↓) in TTI is represented by the respective symbol.
| Factors | Section | Influence | Change of TTI | Conclusion |
|---|---|---|---|---|
| Waveforms |
| low | no change | The biphasic waveform was found to be less sensitive to changes in TTI. The reduction in TTI for the biphasic waveform compared to the monophasic waveform was minimal. |
| Serial shocks |
| low | ↓ with shocks | Not all studies are congruent. More studies reported decrease rather than stable TTI. All recorded decreases were small and SD usually high. |
| Coupling device |
| high | ↓ for good coupling | Correct coupling (with gels/pastes and mechanical coupling of electrodes) at the electrode/tissue layer is a crucial factor for the TTI. |
| Electrode size |
| high | ↓ with electrode size | All studies are congruent. Of particular significance in pediatric defibrillation with very small electrodes. |
| Electrode pressure |
| high | ↓ with pressure | All studies are congruent. For adult defibrillation with paddles, 8 kgf is recommended. |
| Electrode position |
| medium | ↓ in AP | Overall, the TTI was lower in the AP position than in the AA and AL electrode positions (marginal in some studies). The TTI did not differ in the subgroups of the different AA positions nor in the AP positions. A higher TTI was found for the transverse position compared to the longitudinal position. |
| Age |
| medium | ↑ with age | Most of the differences are between adults and children, mainly because of body measurements that change with age. Only one study found TTI generally higher with age. |
| Gender |
| low | ↕ | The results are inconsistent and no trends given. Characteristic differences between sexes can be considered: Breast hair should be removed to allow adequate coupling, on breast positioning of electrodes increases TTI, pregnancy does not affect TTI. |
| Body dimensions |
| medium | ↑ with body dimensions | Different indicators were used in the different studies: weight, chest size, BSA and BMI, making comparison difficult. A small, if any, increase in TTI with increasing body dimensions is indicated. Severely overweight should be considered. |
| Respiration and lung volume |
| low | ↑ with lung volume | Full lung volume may result in a slight increase in TTI. Measurements can be taken at end-expiratory time points to fully compensate for the of respiration. |
| Hemoglobin saturation |
| low | ↑ with Hb O2 saturation | Three studies are congruent: Higher Hb O2 saturation has a slightly increasing effect on TTI. Only of clinical interest in combination with pathological symptoms leading to very atypical Hb O2 saturation values. |
| Pathologies |
| low | ↕ | Mainly minor changes of TTI with pathological symptoms were observed. Severe changes were only documented after sternotomy. In general, the more advanced the pathophysiological symptoms, the greater the change in TTI. |